Retrospective review of outcomes of Multiple Myeloma (MM) patients with COVID-19 infection (two-center study)
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Retrospective review of outcomes of Multiple Myeloma (MM) patients with COVID-19 infection (two-center study)
Authors
Keywords
-
Journal
Clinical Lymphoma Myeloma & Leukemia
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-01-19
DOI
10.1016/j.clml.2023.01.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period
- (2022) Natalia Neparidze et al. LEUKEMIA
- Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study
- (2021) Jongmin Lee et al. Cancers
- Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience
- (2021) Marta Krejci et al. ANNALS OF HEMATOLOGY
- Severe COVID-19 in patients with hematological cancers presenting with viremia
- (2021) J.M. Michot et al. ANNALS OF ONCOLOGY
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with Multiple Myeloma receiving systemic anti‐cancer therapy.
- (2020) Gordon Cook et al. BRITISH JOURNAL OF HAEMATOLOGY
- Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
- (2020) Matt Arentz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)
- (2020) Evangelos Terpos et al. LEUKEMIA
- Estimating the burden of SARS-CoV-2 in France
- (2020) Henrik Salje et al. SCIENCE
- Determinants of COVID-19 disease severity in patients with cancer
- (2020) Elizabeth V. Robilotti et al. NATURE MEDICINE
- Management of patients with multiple myeloma during the COVID-19 pandemic
- (2020) Florent Malard et al. Lancet Haematology
- Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality
- (2020) Joaquín Martínez-López et al. Blood Cancer Journal
- Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set
- (2020) Ajai Chari et al. BLOOD
- Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials
- (2018) Jennifer L. J. Heaney et al. LEUKEMIA
- Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients
- (2014) C. Blimark et al. HAEMATOLOGICA
- Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents
- (2009) Marcio Nucci et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started